GPN Vaccines
Adelaide
About GPN Vaccines
GPN Vaccines is a clinical stage biotechnology company developing a Streptococcus pneumoniae vaccine. The company's vaccine is designed to prevent life-threatening pneumonia, bacteremia, and meningitis, as well as otitis media.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $24.6M
- Funding stage: Early Stage Venture
- Last round: Series B (Jun 2024)
- Website: gpnvaccines.com
- Phone: 08 8313 4671
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/gpn-vaccines-61392 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.